Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by biggdoggon Dec 13, 2023 3:29pm
154 Views
Post# 35782926

RE:Rain cage…. A monster in the making

RE:Rain cage…. A monster in the making They are the real deal, great thread, I think its a credible source. Just wait until the Big Pharma grasps the fact that Voy is real deal with new drug molecules. This realationship is a billion dollar deal in the making for shareholders. Current price fullerene $395/g or $395,000,000 a tonne.  https://www.msesupplies.com/products/mse-pro-high-purity-99-9-fullerene-c60-1g?variant=32089827672122
MRI drugs, Cancer drugs that use imaging to direct them to the tumor, new CT drugs, This is a part of the story Voyaguer needs to promote, as it takes the company to a new levels and FC will be just a revenue generating side story.
Death Threats!? This is very disruptive to the markets they are in.
<< Previous
Bullboard Posts
Next >>